-
GSK and Bharat Biotech to Cut Malaria Vaccine Cost
GSK
GSK and Bharat Biotech plan to reduce the cost of Mosquirix, the world’s first WHO-approved malaria vaccine, to under $5 per dose by 2028, aiming to expand global access and support Gavi’s child immunization goals across Africa.
-
BioNTech Acquires CureVac in $1.25B mRNA Deal
BioNTech
BioNTech acquires CureVac in a $1.25 billion all-stock deal, expanding its mRNA cancer therapy pipeline and resolving ongoing litigation. The acquisition strengthens BioNTech’s oncology strategy and manufacturing capabilities.
-
Kennedy Overhauls CDC Vaccine Committee
HHS
HHS Secretary Robert F. Kennedy Jr. has disbanded the CDC’s vaccine advisory panel, citing conflicts of interest. The sweeping changes raise concerns across the healthcare and pharmaceutical industries.
-
-
金山区|
进贤县|
德化县|
杭州市|
绥滨县|
屯门区|
大荔县|
田林县|
启东市|
旬阳县|
南乐县|
秦皇岛市|
黄骅市|
美姑县|
广宗县|
德州市|
延长县|
深泽县|
池州市|
铜梁县|
甘肃省|
东阳市|
新津县|
观塘区|
盱眙县|
沈丘县|
贵阳市|
波密县|
佛学|
延吉市|
焦作市|
凤凰县|
都江堰市|
靖边县|
吉木萨尔县|
南川市|
武山县|
布尔津县|
磐安县|
密山市|
昆山市|